Project Details
| Status | Active |
|---|---|
| Effective start/end date | 9/12/24 → 8/12/29 |
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Crohn’s Disease
- Moore, Gregory (Primary Chief Investigator (PCI))
Project: Research